FI (list display)

  • A61K49/00
  • Preparations for testing in vivo [3] HB CC 4C085
  • A61K49/04
  • .X-ray contrast preparations [3] HB CC 4C085
  • A61K49/04,100
  • ..including barium sulfates HB CC 4C085
  • A61K49/04,200
  • ..halogen-containing compound HB CC 4C085
  • A61K49/04,210
  • ...iodine-containing compound HB CC 4C085
  • A61K49/06
  • .Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations [2006.01] HB CC 4C085
  • A61K49/08
  • ..characterised by the carrier [7] HB CC 4C085
  • A61K49/10
  • ...Organic compounds [7] HB CC 4C085
  • A61K49/12
  • ....Macromolecular compounds [7] HB CC 4C085
  • A61K49/14
  • ....Peptides, e.g. proteins [7] HB CC 4C085
  • A61K49/16
  • .....Antibodies; Immunoglobulins; Fragments thereof [7] HB CC 4C085
  • A61K49/18
  • ..characterised by a special physical form, e.g. emulsions, microcapsules, liposomes [7] HB CC 4C085
  • A61K49/20
  • ..containing free radicals [7] HB CC 4C085
  • A61K49/22
  • .Echographic preparations; Ultrasound imaging preparations [7] HB CC 4C085
    TOP